I just looked at the capital expenditure for IMU for ?3 P1 trials at 17m.
the CU6 team are managing capital incredibly well in comparison, or that the expenditure for their assets has lower cost requirements.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
14.4%
!
$2.39

I just looked at the capital expenditure for IMU for ?3 P1...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.39 |
Change
0.300(14.4%) |
Mkt cap ! $768.3M |
Open | High | Low | Value | Volume |
$2.09 | $2.40 | $2.07 | $8.519M | 3.760M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | $2.38 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.39 | 4380 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 2.380 |
1 | 34843 | 2.360 |
2 | 11935 | 2.350 |
2 | 24935 | 2.330 |
1 | 9935 | 2.320 |
Price($) | Vol. | No. |
---|---|---|
2.390 | 4380 | 2 |
2.400 | 20983 | 8 |
2.410 | 105000 | 2 |
2.420 | 18610 | 3 |
2.430 | 2000 | 1 |
Last trade - 16.21pm 26/06/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online